Adherence to oral anticancer agents: Healthcare providers' perceptions, beliefs and shared decision making in Belgium and the Netherlands

Mathieu Verbrugghe, Lonneke Timmers, Christel C L M Boons, Bart J. F. van den Bemt, Jacqueline G Hugtenburg, Ann Van Hecke

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

BACKGROUND: Little is known about healthcare providers' (HCPs) perceptions of adherence management of oral anticancer agents (OACA). The study aims to explore HCPs perceptions of OACA and adherence.

METHODS: A cross-sectional, multi-center observational study among HCPs in hemato-oncology settings in Belgium and the Netherlands was conducted. Physicians, nurse practitioners, nurses and pharmacists were asked to complete questionnaires on their perception of patient adherence and its management (PAMQ) and their beliefs about OACA (BMQ-Specific). Physicians were also asked to complete a questionnaire on their perception of shared decision making (SDM-Q-Doc).

RESULTS: The sample consisted of 254 HCPs. Variations were found between HCPs on the PAMQ: 56%, 50%, 28% and 23% of, respectively, physicians, nurse practitioners, nurses and pharmacists reported to know the level of adherence of their patients and 59%, 53%, 43% and 10% of, respectively, physicians, nurse practitioners, nurses and pharmacists think that patients discuss adherence with them. 70%, 82%, 63% and 62% of, respectively, physicians, nurse practitioners, nurses and pharmacists reported to have knowledge of causes of non-adherence, while 78%, 87%, 76% and 80% of them reported to have knowledge of consequences of non-adherence. 81%, 92%, 83% and 67% of, respectively, physicians, nurse practitioners, nurses and pharmacists felt able to influence adherence. Lower concerns beliefs were associated with a higher total score on the PAMQ [β (SE)=-0.85 (0.24); CI -1.33--0.38]. Physicians scored a mean of 75 on the SDM-scale.

CONCLUSIONS: A considerable part of the HCPs states they do not know the adherence of their patients, nor do they think patients discuss adherence with them. However, they feel to have knowledge of adherence and perceive to be able to influence adherence of their patients.

Original languageEnglish
Pages (from-to)437-43
Number of pages7
JournalActa Oncologica
Volume55
Issue number4
DOIs
Publication statusPublished - 2016

Cite this

@article{9dec1bace1984fd386d28b68fd2d27de,
title = "Adherence to oral anticancer agents: Healthcare providers' perceptions, beliefs and shared decision making in Belgium and the Netherlands",
abstract = "BACKGROUND: Little is known about healthcare providers' (HCPs) perceptions of adherence management of oral anticancer agents (OACA). The study aims to explore HCPs perceptions of OACA and adherence.METHODS: A cross-sectional, multi-center observational study among HCPs in hemato-oncology settings in Belgium and the Netherlands was conducted. Physicians, nurse practitioners, nurses and pharmacists were asked to complete questionnaires on their perception of patient adherence and its management (PAMQ) and their beliefs about OACA (BMQ-Specific). Physicians were also asked to complete a questionnaire on their perception of shared decision making (SDM-Q-Doc).RESULTS: The sample consisted of 254 HCPs. Variations were found between HCPs on the PAMQ: 56{\%}, 50{\%}, 28{\%} and 23{\%} of, respectively, physicians, nurse practitioners, nurses and pharmacists reported to know the level of adherence of their patients and 59{\%}, 53{\%}, 43{\%} and 10{\%} of, respectively, physicians, nurse practitioners, nurses and pharmacists think that patients discuss adherence with them. 70{\%}, 82{\%}, 63{\%} and 62{\%} of, respectively, physicians, nurse practitioners, nurses and pharmacists reported to have knowledge of causes of non-adherence, while 78{\%}, 87{\%}, 76{\%} and 80{\%} of them reported to have knowledge of consequences of non-adherence. 81{\%}, 92{\%}, 83{\%} and 67{\%} of, respectively, physicians, nurse practitioners, nurses and pharmacists felt able to influence adherence. Lower concerns beliefs were associated with a higher total score on the PAMQ [β (SE)=-0.85 (0.24); CI -1.33--0.38]. Physicians scored a mean of 75 on the SDM-scale.CONCLUSIONS: A considerable part of the HCPs states they do not know the adherence of their patients, nor do they think patients discuss adherence with them. However, they feel to have knowledge of adherence and perceive to be able to influence adherence of their patients.",
keywords = "Administration, Oral, Antineoplastic Agents, Attitude of Health Personnel, Belgium, Cross-Sectional Studies, Decision Making, Female, Health Personnel, Hematologic Neoplasms, Humans, Male, Netherlands, Nurses, Patient Compliance, Physicians, Surveys and Questionnaires, Journal Article, Multicenter Study, Observational Study",
author = "Mathieu Verbrugghe and Lonneke Timmers and Boons, {Christel C L M} and {van den Bemt}, {Bart J. F.} and Hugtenburg, {Jacqueline G} and {Van Hecke}, Ann",
year = "2016",
doi = "10.3109/0284186X.2015.1119307",
language = "English",
volume = "55",
pages = "437--43",
journal = "Acta Oncologica",
issn = "0284-186X",
publisher = "Informa Healthcare",
number = "4",

}

Adherence to oral anticancer agents : Healthcare providers' perceptions, beliefs and shared decision making in Belgium and the Netherlands. / Verbrugghe, Mathieu; Timmers, Lonneke; Boons, Christel C L M; van den Bemt, Bart J. F.; Hugtenburg, Jacqueline G; Van Hecke, Ann.

In: Acta Oncologica, Vol. 55, No. 4, 2016, p. 437-43.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Adherence to oral anticancer agents

T2 - Healthcare providers' perceptions, beliefs and shared decision making in Belgium and the Netherlands

AU - Verbrugghe, Mathieu

AU - Timmers, Lonneke

AU - Boons, Christel C L M

AU - van den Bemt, Bart J. F.

AU - Hugtenburg, Jacqueline G

AU - Van Hecke, Ann

PY - 2016

Y1 - 2016

N2 - BACKGROUND: Little is known about healthcare providers' (HCPs) perceptions of adherence management of oral anticancer agents (OACA). The study aims to explore HCPs perceptions of OACA and adherence.METHODS: A cross-sectional, multi-center observational study among HCPs in hemato-oncology settings in Belgium and the Netherlands was conducted. Physicians, nurse practitioners, nurses and pharmacists were asked to complete questionnaires on their perception of patient adherence and its management (PAMQ) and their beliefs about OACA (BMQ-Specific). Physicians were also asked to complete a questionnaire on their perception of shared decision making (SDM-Q-Doc).RESULTS: The sample consisted of 254 HCPs. Variations were found between HCPs on the PAMQ: 56%, 50%, 28% and 23% of, respectively, physicians, nurse practitioners, nurses and pharmacists reported to know the level of adherence of their patients and 59%, 53%, 43% and 10% of, respectively, physicians, nurse practitioners, nurses and pharmacists think that patients discuss adherence with them. 70%, 82%, 63% and 62% of, respectively, physicians, nurse practitioners, nurses and pharmacists reported to have knowledge of causes of non-adherence, while 78%, 87%, 76% and 80% of them reported to have knowledge of consequences of non-adherence. 81%, 92%, 83% and 67% of, respectively, physicians, nurse practitioners, nurses and pharmacists felt able to influence adherence. Lower concerns beliefs were associated with a higher total score on the PAMQ [β (SE)=-0.85 (0.24); CI -1.33--0.38]. Physicians scored a mean of 75 on the SDM-scale.CONCLUSIONS: A considerable part of the HCPs states they do not know the adherence of their patients, nor do they think patients discuss adherence with them. However, they feel to have knowledge of adherence and perceive to be able to influence adherence of their patients.

AB - BACKGROUND: Little is known about healthcare providers' (HCPs) perceptions of adherence management of oral anticancer agents (OACA). The study aims to explore HCPs perceptions of OACA and adherence.METHODS: A cross-sectional, multi-center observational study among HCPs in hemato-oncology settings in Belgium and the Netherlands was conducted. Physicians, nurse practitioners, nurses and pharmacists were asked to complete questionnaires on their perception of patient adherence and its management (PAMQ) and their beliefs about OACA (BMQ-Specific). Physicians were also asked to complete a questionnaire on their perception of shared decision making (SDM-Q-Doc).RESULTS: The sample consisted of 254 HCPs. Variations were found between HCPs on the PAMQ: 56%, 50%, 28% and 23% of, respectively, physicians, nurse practitioners, nurses and pharmacists reported to know the level of adherence of their patients and 59%, 53%, 43% and 10% of, respectively, physicians, nurse practitioners, nurses and pharmacists think that patients discuss adherence with them. 70%, 82%, 63% and 62% of, respectively, physicians, nurse practitioners, nurses and pharmacists reported to have knowledge of causes of non-adherence, while 78%, 87%, 76% and 80% of them reported to have knowledge of consequences of non-adherence. 81%, 92%, 83% and 67% of, respectively, physicians, nurse practitioners, nurses and pharmacists felt able to influence adherence. Lower concerns beliefs were associated with a higher total score on the PAMQ [β (SE)=-0.85 (0.24); CI -1.33--0.38]. Physicians scored a mean of 75 on the SDM-scale.CONCLUSIONS: A considerable part of the HCPs states they do not know the adherence of their patients, nor do they think patients discuss adherence with them. However, they feel to have knowledge of adherence and perceive to be able to influence adherence of their patients.

KW - Administration, Oral

KW - Antineoplastic Agents

KW - Attitude of Health Personnel

KW - Belgium

KW - Cross-Sectional Studies

KW - Decision Making

KW - Female

KW - Health Personnel

KW - Hematologic Neoplasms

KW - Humans

KW - Male

KW - Netherlands

KW - Nurses

KW - Patient Compliance

KW - Physicians

KW - Surveys and Questionnaires

KW - Journal Article

KW - Multicenter Study

KW - Observational Study

U2 - 10.3109/0284186X.2015.1119307

DO - 10.3109/0284186X.2015.1119307

M3 - Article

VL - 55

SP - 437

EP - 443

JO - Acta Oncologica

JF - Acta Oncologica

SN - 0284-186X

IS - 4

ER -